Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Barcoview — Predicate Candidate Screening
17 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
32 daysmedian FDA review time
114 days90th percentile
17clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K062621 | NIO 5MP-21 AND MDNG-5121 CB | Barcoview | 2007-03-19 | 195 | 0 |
| K062905 | NIO FUSION 4MP; MDNC 4130 | Barcoview | 2006-12-29 | 93 | 0 |
| K062131 | NIO 5MP-M-21 (NIO 5MP MAMMO); MDNG-5121 BB | Barcoview | 2006-11-17 | 114 | 0 |
| K061927 | CORONIS COLOR 3MP AND MDCC 3120-DL | Barcoview | 2006-09-05 | 60 | 0 |
| K061924 | CORONIS 3MP AND MDCG 3120-CB | Barcoview | 2006-09-05 | 60 | 0 |
| K061928 | CORONIS COLOR 2MP AND MDCC 2121 | Barcoview | 2006-09-05 | 60 | 0 |
| K061926 | CORONIS 2MP AND MDCG 2121 - CB | Barcoview | 2006-08-18 | 42 | 0 |
| K052958 | COLOR NIO 2MP, E-2320 C | Barcoview | 2005-11-16 | 26 | 0 |
| K052352 | COLOR CORONIS 2MP-21 AND MFCD 2321 | Barcoview | 2005-09-30 | 32 | 0 |
| K052529 | E-2320 PA S | Barcoview | 2005-09-30 | 16 | 0 |
| K052478 | MFCD 1219, MFCD 1219 TS | Barcoview | 2005-09-28 | 19 | 0 |
| K052276 | NIO 2MP-20 AND E-2620 S | Barcoview | 2005-09-21 | 30 | 0 |
| K052429 | CORONIS 3MP-21 AND MFGD 3621 | Barcoview | 2005-09-15 | 9 | 0 |
| K052403 | CORONIS 2MP-21 AND MFGD 2621 | Barcoview | 2005-09-15 | 14 | 0 |
| K051901 | NIO 3MP-21 | Barcoview | 2005-08-17 | 35 | 0 |
| K051902 | NIO 2MP-21 | Barcoview | 2005-08-11 | 29 | 0 |
| K051201 | E1 MEDICAL FLAT PANEL DISPLAY SYSTEM AND MFGD 1218 MEDICAL F | Barcoview | 2005-05-26 | 15 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda